Oxford Nanopore Technologies plc (LON:ONT – Get Free Report) shares fell 10.2% during trading on Monday . The company traded as low as GBX 127 ($1.60) and last traded at GBX 128.50 ($1.62). 3,354,197 shares were traded during mid-day trading, an increase of 54% from the average session volume of 2,182,529 shares. The stock had previously closed at GBX 143.10 ($1.80).
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on ONT shares. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and set a GBX 190 ($2.39) target price on shares of Oxford Nanopore Technologies in a research report on Wednesday, September 4th. JPMorgan Chase & Co. reaffirmed an “overweight” rating on shares of Oxford Nanopore Technologies in a research report on Friday, December 6th. Finally, Berenberg Bank reissued a “buy” rating and issued a GBX 282 ($3.54) price target on shares of Oxford Nanopore Technologies in a research report on Tuesday, September 3rd. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of GBX 235.50 ($2.96).
Read Our Latest Research Report on Oxford Nanopore Technologies
Oxford Nanopore Technologies Stock Performance
Insider Buying and Selling at Oxford Nanopore Technologies
In other Oxford Nanopore Technologies news, insider Gurdial (Gordon) Sanghera sold 1,993,571 shares of the business’s stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of GBX 142 ($1.78), for a total transaction of £2,830,870.82 ($3,558,158.40). Insiders have purchased a total of 310 shares of company stock worth $45,010 in the last quarter. 32.62% of the stock is owned by insiders.
Oxford Nanopore Technologies Company Profile
Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.
Featured Articles
- Five stocks we like better than Oxford Nanopore Technologies
- What Are Dividend Contenders? Investing in Dividend Contenders
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- Pros And Cons Of Monthly Dividend Stocks
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- How to buy stock: A step-by-step guide for beginners
- Market Overreaction: 2 Stocks to Buy on the Way Down
Receive News & Ratings for Oxford Nanopore Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Nanopore Technologies and related companies with MarketBeat.com's FREE daily email newsletter.